Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Dialysis access · Washington | Dialysis access · California | |
|---|---|---|
| Surgeons, 2024 | 30 | 204 |
| Medicare fee-for-service cases | 2,051 | 20,282 |
| Growth since 2019 (Medicare FFS) | −12%/yr | −7.2%/yr |
| Forecast cases (Medicare FFS) | 1,780 in 2030 | 20,800 in 2030 |
| Forecast growth | −2.4%/yr to 2030 | +0.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 2.8 | 6.3 |
| Medicare Advantage share | 54% | 56% |
| Out of hospital | 19% (−3 pts since 2019) | 68% (+13 pts since 2019) |
| Cases per surgeon | 68 | 99 |
| Top 10 surgeons' share | 66% | 34% |
| Surgeons growing | 2 | 34 |
| New since the base year | 3 | 34 |
| Likely to stop billing it | 8 by 2026 | 36 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $35 | $54 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.